Summary of Key Points
Tech billionaires in Silicon Valley are acting as guinea pigs, experimenting with various unproven anti-aging methods (such as receiving plasma from young people, injecting growth hormones, consuming the textile dye methylene blue, and administering synthetic peptides from the gray market). Most of these methods are based solely on animal data with no evidence of extending human life, and they come with significant side effects. Even more dangerous is that they promote these “self-experiments” as standard treatments through social media, leading ordinary people to blindly follow suit and expose themselves to health risks. Meanwhile, potentially effective and inexpensive anti-aging drugs (like metformin) face difficulties in advancing clinical trials due to a lack of commercial interest, highlighting the contradictions between science, commerce, and regulation in the field of longevity.
1. Silicon Valley Billionaires’ List of “Life-Prolonging Remedies”: From Young Plasma to Synthetic Peptides
The list of anti-aging treatments tried by these billionaires is diverse:
- Receiving plasma from young people: They hope to reverse aging with “young blood,” but the FDA has warned twice that there is no evidence to support this.
- Injecting growth hormones: Peter Thiel claims he wants to live to 120 years old, yet Mayo Clinic states the risks outweigh the benefits.
- Consuming methylene blue: Originally a textile dye used for rare blood diseases, it’s marketed as a cognitive enhancer; users swallow it directly through straws to avoid a blue tongue.
- Injecting synthetic peptides: Peptides like BPC-157 and TB-500 (referred to as the “Wolverine combo”) are not approved by the FDA but are injected at “peptide parties” in Silicon Valley.
- Rapamycin: Originally an anti-rejection drug for organ transplants, Brian Johnson tried it for five years, experiencing numerous side effects (skin infections, increased blood sugar and lipids), and eventually stopped using it while exploring other methods.
These methods all share one commonality: they skip human clinical trials and use the billionaires themselves as test subjects.
2. Scientific Evidence? Good in Animals, but Almost None in Humans
Why do these methods attract billionaires? Because animal data looks promising. For example, rapamycin can extend the lifespan of mice by 23%-60%, but it fails to have the same effect on humans:
- Johnson’s five-year trial showed no life extension and was accompanied by side effects.
- A few formal human trials (like the PEARL study) found no change in visceral fat after 48 weeks, with only minor improvements in some secondary indicators (and at insufficient drug doses).
- Other methods are even more questionable: there are no proper human studies for young plasma and synthetic peptides, and the FDA has warned they are ineffective or risky.
Experts summarize: “Animal data does not equate to human results; these methods lack any evidence of potential effectiveness.”
3. How Do Billionaires’ “Self-Experiments” Become Standard Treatments for Ordinary People?
Social media plays a crucial role in spreading these practices:
- Johnson’s Blueprint treatment has become a popular package, with customers requesting it without undergoing any checks.
- Use of synthetic peptides has spread from Silicon Valley to athletes and teenagers looking to build muscle; doctors in Toronto report a surge in inquiries in the past year.
- At the 2025 Anti-Aging Conference in Las Vegas, two people were urgently hospitalized after receiving unknown peptides; it’s still unclear what was injected.
The reason is simple: billionaires have influence, and they present their personal experiences as scientific findings, which ordinary people believe because they think “if the rich are using it, it must be reliable.”
4. Why Are Genuine Anti-Aging Studies Moving Slowly?
Some promising methods are hindered by lack of funding:
- Metformin: An inexpensive diabetes drug that shows potential anti-aging effects in clinical studies, but pharmaceutical companies are reluctant to fund trials due to low profits; the TAME trial has not started due to funding issues.
- GLP-1 receptor agonists (like Ozempic): While effective for weight loss and affecting aging markers, they are primarily used for diabetes/obesity and not specifically for longevity.
- Despite having the means (a small fraction of their net worth would cover a proper trial), billionaires prefer to try unproven methods rather than invest in legitimate research.
Experts lament: “They’d rather use themselves as guinea pigs than support real scientific research.”
5. Regulators Falling Short, Commercial Interests Compromising Integrity
The spread of these practices is fueled by regulatory gaps and commercial interests:
- Regulatory loopholes: The FDA has banned 19 peptides, but some (like those promoted by Robert Kennedy Jr.) are being reconsidered, with experts criticizing the lack of scientific basis and hasty decision-making.
- Commercial drive: Many longevity influencers sell supplements, marketing them as products to make money, without their followers realizing the underlying commercial motives.
- **“Shadow phase II trials”: Billionaires’ self-experiments bypass formal phase II trials and present results as standards, which are often unreliable.
The ultimate victims are ordinary people, who pay with their health for the billionaires’ curiosity.
Conclusion
Longevity research is not a scam, but the Silicon Valley billionaires’ experiments more closely resemble a health trend than genuine scientific inquiry. True anti-aging breakthroughs require rigorous clinical trials, not individual experiments by the wealthy. Ordinary people should avoid following such fads, as they are part of a “game” that most cannot afford to participate in and lose in.